Display options
Share it on

Lancet Reg Health West Pac. 2020 Oct 09;4:100042. doi: 10.1016/j.lanwpc.2020.100042. eCollection 2020 Nov.

Community-based management of epilepsy in Southeast Asia: Two intervention strategies in Lao PDR and Cambodia.

The Lancet regional health. Western Pacific

Farid Boumediene, Channara Chhour, Phetvonsinh Chivorakoun, Vimalay Souvong, Peter Odermatt, Chamroeun Hun, Clémence Thebaut, Mayoura Bounlu, Navuth Chum, Somchit Vorachit, Sina Ros, Samleng Chan, Pierre-Marie Preux

Affiliations

  1. INSERM U1094, Univ. Limoges, CHU Limoges, IRD, Neuroépidémiologie Tropicale, Institut d'Epidémiologie et de Neurologie Tropicale, GEIST, 2 rue du Docteur Marcland, 87025 Limoges, France.
  2. Cambodia Society of Neurology, Phnom Penh, Cambodia.
  3. Association for Patient with Epilepsy in Laos, Vientiane, Lao Democratic People's Republic.
  4. Swiss Tropical and Public Health Institute, Basel, Switzerland.
  5. University of Basel, Basel, Switzerland.

PMID: 34327389 PMCID: PMC8315387 DOI: 10.1016/j.lanwpc.2020.100042

Abstract

BACKGROUND: Epilepsy affects more than 50 million people worldwide, 80% of whom live in low- and middle-income countries (LMICs). In Southeast Asia, the prevalence is moderate (6‰), and the main public health challenge is reducing the treatment gap, which reaches more than 90% in rural areas.

METHODS: This 12-month comparative study (intervention vs. control areas) assessed the community effectiveness of two different strategies for the identification and home follow-up of people with epilepsy by Domestic Health Visitors for epilepsy (DHVes). In Lao PDR, DHVes were health center staff covering several villages via monthly visits; in Cambodia, DHVes were health volunteers living in the villages.

FINDINGS: At baseline, the treatment gap was >95% in Lao PDR and 100% in Cambodia. After 12 months, the treatment gap in Lao PDR decreased by 5·5% (range: 4·0-12·2) in the intervention area and 0·5% (range: 0·4-0·8) in the control area (

INTERPRETATION: The treatment gap was significantly reduced with both intervention strategies, but the effect was larger in Cambodia. The results of this cost analysis pave the way for scaling-up in rural areas of Lao PDR and Cambodia, and experimental adaptation in other LMICs.

FUNDING: The study was funded by the Global Health Department of Sanofi and Grand Challenges Canada (grant number 0325-04).

© 2020 The Author(s).

Conflict of interest statement

Dr. Boumediene, Dr. Preux, Dr. Hun, Dr. Thebaut, Dr. Chhour, Dr. Chum, Dr. Ros, and Dr. Samleng report grants from Sanofi Global Health Programs,  during the conduct of the study; Dr. Boumediene and D

References

  1. Epilepsy Behav. 2011 Jul;21(3):255-60 - PubMed
  2. Neurology. 2020 Jan 28;94(4):165-175 - PubMed
  3. Bull World Health Organ. 2015 Feb 1;93(2):118-24 - PubMed
  4. Epilepsia. 2010 May;51(5):883-90 - PubMed
  5. Epilepsia. 2011 Aug;52(8):1376-81 - PubMed
  6. Neuroepidemiology. 2006;26(4):199-206 - PubMed
  7. Lancet Neurol. 2013 Mar;12(3):253-63 - PubMed
  8. Nature. 2018 Jul;559(7715):507-516 - PubMed
  9. Bull Soc Pathol Exot. 2006 May;99(2):103-7 - PubMed
  10. Bull Soc Pathol Exot. 2000 Nov;93(4):276-8 - PubMed
  11. Epilepsia. 2014 Jan;55(1):76-85 - PubMed
  12. Epilepsy Behav. 2018 Nov;88:74-80 - PubMed
  13. Epilepsia. 2013 Aug;54(8):1352-9 - PubMed
  14. Lancet Neurol. 2007 Jun;6(6):533-43 - PubMed
  15. Epilepsia. 1993 Jul-Aug;34(4):592-6 - PubMed
  16. Lancet Neurol. 2006 Oct;5(10):823-7 - PubMed
  17. Epilepsia. 2008 Sep;49(9):1491-503 - PubMed
  18. N Engl J Med. 2020 Feb 20;382(8):717-726 - PubMed
  19. Bull World Health Organ. 2008 Dec;86(12):964-9 - PubMed
  20. Epilepsia. 2011 Aug;52(8):1382-7 - PubMed
  21. Epilepsia. 2011 Sep;52 Suppl 7:2-26 - PubMed
  22. Lancet Neurol. 2005 Mar;4(3):171-8 - PubMed
  23. Epilepsia. 2019 Mar;60 Suppl 1:7-21 - PubMed
  24. Epilepsia. 2001 Jan;42(1):136-49 - PubMed
  25. Med Care. 1986 Jan;24(1):67-74 - PubMed

Publication Types